- Report
- August 2025
- 194 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2024
- 191 Pages
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- August 2025
- 198 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- August 2025
- 199 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 194 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 183 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 190 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,425GBP
- Report
- September 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,937GBP
- Report
- May 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,937GBP
€4275EUR$4,850USD£3,699GBP
- Report
- June 2025
- 299 Pages
Global
From €5157EUR$5,850USD£4,462GBP
- Report
- August 2022
- 115 Pages
Global
From €3967EUR$4,500USD£3,432GBP

Cardiac glycosides are a class of drugs used to treat heart failure and abnormal heart rhythms. They work by increasing the force of contraction of the heart muscle, which helps the heart pump more efficiently. Cardiac glycosides are also used to treat certain types of arrhythmias, or irregular heartbeats. These drugs are typically prescribed in combination with other medications, such as diuretics and ACE inhibitors.
Cardiac glycosides are an important part of the cardiovascular drug market. They are used to treat a variety of conditions, including heart failure, arrhythmias, and hypertension. They are also used to reduce the risk of stroke and other cardiovascular events. Cardiac glycosides are generally well-tolerated and have few side effects.
Some of the companies in the cardiac glycoside market include Sanofi, Pfizer, Merck, and Novartis. These companies produce a variety of cardiac glycoside medications, including digoxin, lanatoside C, and ouabain. Show Less Read more